Clominorex

This classification denotes an anorexiant with the molecular formula C9H9ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) O1R2462WA0, chemically known as 5-(4-chlorophenyl)-1,3-oxazolidin-2-imine but more generally known as clominorex, which bears US NIH Compound Identifier 19752. European Medicines Agency schedules Clominorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06724MIG. The term CLOMINOREX is an International Non-Proprietary Name. CLOMINOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule clominorex under HS 29349990 and SITC 51579. As of Q4 2014, CLOMINOREX remains US FDA's Preferred Term for this commodity. Clominorex bears US NLM identifiers UMLS ID C2347809 and NCI Concept Code C72177. SMILES: CLC1CCC(C2OC(=NC2)N)CC1.